Tolerion, Inc. — Form D
Tolerion, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-02-10. The offering totals $29.8M, of which $23.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-02-10
- Form: D
- Accession: 0001733538-20-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $29.8M
- Amount sold: $23.0M
- Remaining: $6.7M
- Investors: 12
- Date of first sale: 2017-12-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-360181
Issuer
- Name: Tolerion, Inc.
- CIK: 0001733538
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 131 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Phone: 415-795-5800
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| John Donovan | Director | Houston, TX |
| Paul Manning | Director | Charlottesville, VA |
| Sean Stalfort | Director | Charlottesville, VA |
| Lawrence Steinman | Director | San Carlos, CA |
| STEPHEN ZACHARY | Director | ARLINGTON, VA |
| Graeme Curie | Executive Officer | South San Francisco, CA |
| John Donovan | Executive Officer | Houston, TX |
| Alexander Fleming | Executive Officer | South San Francisco, CA |
| Scott Geyer | Executive Officer | South San Francisco, CA |
| Randolph Johnson | Executive Officer | South San Francisco, CA |
| James Stutz | Executive Officer | South San Francisco, CA |
Other filings by this issuer (1)
More